Ferric Citrate Hydrate

枸橼酸铁

Report date: 2026/05/20 20:02:01

Base Information

Drug NameFerric Citrate Hydrate
Drug Alias Name柠檬酸铁Ferric citrateFerric citrate dihydrate柠檬酸铁水合物Tetraferric tricitrate decahydrate +[16] 
ClassificationSmall molecules > Inorganic and minerals salt
Mechanisms of ActionPhosphate-binding proteins modulatorsIron replacements
TargetsPhosphate-binding proteins
Therapy Area/IndicationsIron deficiencyDisease ProgressionHyperphosphatemia +[11] 
Global Approved IndicationsHyperphosphatemiaAnemiaKidney Failure, Chronic +[4] 
Approved Indications in ChinaHyperphosphatemiaKidney Failure, Chronic
Original Approved Country/TerritoryJapan
Original Approved Date2014/01/17
Country/TerritoryCanadaUnited StatesTaiwan +[10] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPanion & Bf Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesDhaka Medical CollegeMugdha Medical College and HospitalShaheed Suhrawardy Medical College and Hospital +[11] 
Inactive CompaniesDenver Nephrologists PcPanion & Bf Biotech Inc Pingjhen PlantLhasa Sino-Philippines Biological Technology Co Ltd +[8] 
Active IndicationsDisease ProgressionHyperphosphatemiaAnemia, Iron-Deficiency +[8] 
Inactive IndicationsIron deficiencyRenal InsufficiencyKidney Diseases

Other Information

ATC CodeV03AE08
Related LinksWikipediaDrugBankKEGG